Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects
Clinical trial NCT07054255 · COMPLETED
Trial details
- NCT number
- NCT07054255
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-06
- Primary completion
- 2020-11-09
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.